Fredrick Hausheer
Geen lopende functies
Profiel
Fredrick Herman Hausheer was the founder and had founded BioNumerik Pharmaceuticals, Inc. in 1992, where he held the title of Chairman & Chief Executive Officer until 2015.
He has held former positions as Global Chief Medical Officer & Senior VP at Shanghai Stock Exchange and Wuxi Apptec, Inc. from 2019 to 2020, and as Global Chief Medical Officer at Lepu Biopharma Co., Ltd.
from 2020 to 2022.
Mr. Hausheer has a doctorate degree from the University of Missouri in 1982, an undergraduate degree from Graceland University in 1977, and a graduate degree from the University of Illinois At Urbana–Champaign in 1979.
Eerdere bekende functies van Fredrick Hausheer
| Bedrijven | Functie | Einde |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Hoofd Techniek/Wetenschap/O&O | 31-03-2022 |
Wuxi Apptec, Inc.
 Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Hoofd Techniek/Wetenschap/O&O | 01-10-2020 |
Shanghai Stock Exchange
 Shanghai Stock Exchange Investment Banks/BrokersFinance Shanghai Stock Exchange provides marketplace and facilities for securities trading. Its services include formulating business rules, accepting and arranging listings, organizing and monitoring securities trading, regulating members & listed companies, managing, and disseminating market information. The company was founded on November 26, 1990 and is headquartered in Shangha, China | Verkoop & Marketing | 01-10-2020 |
BioNumerik Pharmaceuticals, Inc.
 BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Algemeen Directeur | 01-06-2015 |
Opleiding van Fredrick Hausheer
| Graceland University | Undergraduate Degree |
| University of Illinois At Urbana–Champaign | Graduate Degree |
| University of Missouri | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Wuxi Apptec, Inc.
Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Technology Services |
Shanghai Stock Exchange
Shanghai Stock Exchange Investment Banks/BrokersFinance Shanghai Stock Exchange provides marketplace and facilities for securities trading. Its services include formulating business rules, accepting and arranging listings, organizing and monitoring securities trading, regulating members & listed companies, managing, and disseminating market information. The company was founded on November 26, 1990 and is headquartered in Shangha, China | Finance |
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Health Technology |
